2024-03-31 10:47:12 ET
Summary
- Eli Lilly's stock has surged in the first quarter of 2024 due to the success of its weight loss products in the pharma market.
- A huge rally has powered the shares to a gain of 130% over the past 12 months and the stock to a $700 billion market cap.
- In the article below, three key threats that could result to some significant profit taking in the stock are highlighted.
Few large cap stocks have rewarded its shareholders more in the first quarter of 2024 than that of drug giant Eli Lilly ( LLY ) . The shares are up by a third year to date and some 130% over the past 12 months. The rally has been powered by the company's new weight management products in what is a huge new market in the pharma space....
Read the full article on Seeking Alpha
For further details see:
Eli Lilly: Three Threats To Its Huge Rally